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OPENThe effectiveness of yoga to prevent diabetes
mellitus type 2
A protocol for systematic review and meta-analysis
Ramya Ramamoorthi, BVSc, GCTLHEa,
∗
, Daniel Gahreman, PhDa, Simon Moss, PhDa,
Timothy Skinner, MTEM, PhDbAbstract
Background: Type 2 diabetes mellitus (T2DM) is becoming a leading problem worldwide. Emerging reports reveal alarming
evidence of increasing prevalence of T2DM that has reached pandemic levels. Despite the signiﬁcant incidence, there are limited
reliable data resources and comprehensive systematic review and meta-analysis on the effects of yoga on people who are a
prediabetic or high risk for developing T2DM.
Objective: The objective of this protocol is to conduct a full-scale systematic review and meta-analyses on the effects of yoga on
people who are prediabetes or high risk of developing T2DM.
Methods:The articles enrolled in the study will be retrieved from the online databases between 2002 and the date the searches are
executed. The searches will be repeated just before the ﬁnal analyses and further relevant studies for inclusion. We will conduct a
bibliographic search in databases: Medline/PubMed, Scopus, Cochrane Library, EBSCO, and IndMED using keywords including
prediabetes state, high risk for diabetes, metabolic syndrome, and yoga. A deﬁned search strategy will be implemented along with
selection criteria to obtain full-text articles of relevant studies. This study protocol was prepared according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analysis for Protocols 2015 guidelines. There will be no language restrictions.
Ethics and dissemination: The proposed study will be based on published studies and publicly available anonymized data
without directly involving human participants and therefore requires neither formal human ethical review nor approval by a human
research ethics committee. We published an outline of the protocol in the International Prospective Register of Systematic Reviews
(PROSPERO) in 2018. We plan to disseminate the ﬁndings of this systematic review and meta-analysis through publication in a peer-
reviewed journal and presentation at relevant conference proceedings. In addition, we believe the results of the systematic review will
have implications for policy and practice. We will prepare policymaker summary using a validated format, disseminate through social
media and email discussion groups.
Review registration number: PROSPERO registration number CRD 42018106657
Abbreviations: CMA = comprehensive meta-analysis, DBP = diastolic blood pressure, FBG = fasting blood glucose, HbA1c =
hemoglobin A1C, HDL = high-density lipoprotein, LDL = low-density lipoprotein, PPBG = postprandial blood glucose, PRISMA-P =
Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Protocols, PROSPERO = the protocol in the International
Prospective Register of Systematic Reviews, SBP = systolic blood pressure, SMD = standardized mean difference, T2DM = type 2
diabetes mellitus, TC = total cholesterol, VLDL = very low-density lipoproteins.
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11. Introduction
Type 2 diabetes mellitus (T2DM) is one of the greatest public
health challenges in today’s world.[1] The body becomes either
resistant to insulin or gradually loses the ability to produce
insulin.[2] According to the World Health Organization, global
report on diabetes incidence, an estimated 422 million people
were found to be living with diabetes in 2014.[3] International
Diabetes Federation reported that it is estimated that there will be
629 million people with diabetes by the end of 2045, and
diabetes-related health expenditure will exceed US$776 billion.[4]
The development and maintenance of T2DM are attributed to
sedentary lifestyle,[5] unhealthy diet, and psychologic stress.
Psychologic stress has a strong correlation with both the risk
factors[6–8] and maintenance of the disease.[9,10] Several acquired
risk factors such as prediabetic state contribute to the develop-
ment of T2DM apart from the genetic background.[5,11]
Ramamoorthi et al. Medicine (2019) 98:3 MedicineMany complementary and alternative practices are explored
by people in both the prevention and treatment of diabetes.[12,13]
Yoga is one such Eastern practice that originated in India over
5000 years ago principally to develop mental faculties.[14,15]
Yoga advocates that a healthy body is a by-product of healthy
mind.[16,17] Most importantly, a growing body of research
suggests that the practice of yoga may reduce insulin resistance
syndrome and may attenuate signs, reduce complications, and
improve the prognosis of diabetes.[18–23] Also, studies have
shown that the progression of diabetic condition from prediabe-
tes could be either delayed or halted with regular physical
activity,[24–27] healthy diet,[27] and effective stress manage-
ment.[28,29]
It is proposed yoga intervenes T2DM by 2 proposed
mechanisms downregulation of both the hypothalamic pituitary
adrenal axis and the sympathetic nervous system.[30–32]2. Rationale
2.1. What is the issue and how will our study address
this?
Several studies in the prediabetic population show the effective-
ness of yoga in reducing the risk of progression to diabetic
state.[33–36] There is not a single review to show the beneﬁts of
yoga in prediabetes. This will be the 1st systematic review that
will show evidence that yoga signiﬁcantly affects the prediabetic
state and will summarize the results of these available studies.
This study will announce the gaps in present research and will set
directions for future research. The study will further provide
evidence for people to adopt yoga practise as an attractive
alternative to other forms of physical training especially for
people who are discouraged by the perceived rigor of other
exercises.2.2. Review questions
The aim of our systematic review andmeta-analysis protocol is to
describe the methodologic approach for conducting a systematic
review andmeta-analysis to examine the effects of yoga on people
who are prediabetic or high risk for developing T2DM.
The questions for this review are as follows:1.T
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23. Methods3.1. Search strategy and study selection
The proposed systematic review and meta-analysis will be
performed according to the guidelines of Preferred Reporting
Items for Systematic Review and Meta-Analysis (PRISMA)
statement issued in 2015. The authors will consider the published
studies explaining the effectives of yoga in prediabetic and
metabolic syndrome with no restrictions on study participant’s
age, ethnicity, morbidity, and occupation. There will be no
language restrictions. The authors will perform a literature search
using 5 computerized English and Indian scientiﬁc electronic
bibliographic databases: PubMed, Scopus, Cochrane Library,
EBSCO, and IndMED. The search strategy will include only
search terms related to “yoga” and “cardiovascular disease risk
factors” and adapted for each database as necessary. Studies
published between 2002 and the date the searches executed will
be sought. The searches will be repeated just before the ﬁnal
analyses. Many searches in the proposed study will be
undertaken to ensure the identiﬁcation of eligible studies using
one of the several search term combinations for the effectiveness
of yoga on the high risk of diabetes or prediabetic population or
metabolic syndrome (prediabetes state, high risk for diabetes,
metabolic syndrome, and yoga). Keywords used were: “yoga
[abstract],” “prediabetes [abstract],” and “glucose [text].”
Keywords used included yoga + type 2 diabetes [in the title of
the article], yoga + type II diabetes [in the title of the article], and
exercise therapy + type 2 diabetes patients [in the title of the
article].3.2. Search strategy
A draft search strategy for the databases and search string that
will be used to identify the studies describing effects of yoga in
prediabetic and metabolic syndrome is shown in Table 1.3.3. Study selection criteria
3.3.1. Inclusion criteria.1.pus
2
2
3
0Study examining yoga intervention (including at least one of
asana, pranayama, meditation) to promote T2DM manage-
ment and comparing yoga intervention with other usual care
or physical exercise or nontherapeutic intervention.
Study that is randomized control trial, randomized cross-over2.
studies, cluster-randomized trials, or quasi-experimental
design will be included.
Studies evaluating the primary outcome measure-glycemic3.
control, measured in both the intervention and control groupBibliographic databases
PubMed COCHRANE Library EBSCO host INDMED
63 32 145 1
33 28 112 0
34 1 112 0
35 5 25 0
11 5 22 0
10 5 22 7
11 5 22 5
9 4 12 1
Ramamoorthi et al. Medicine (2019) 98:3 www.md-journal.comconditions as well as other measures such as HbA1c, blood
pressure, or fasting blood sugar, and lipid proﬁle (triglycer-
ides, high-, and low-density lipoprotein [HDL and LDL]
cholesterol, systolic blood pressure [SBP], and diastolic blood
pressure [DBP]) will be included.
Study participants must be prediabetic or designated as high4.
risk for diabetes because of physiologic measures, and the
outcomes must be reported speciﬁcally for each group
3.3.2. Exclusion criteria.1. Studies will be excluded if participants were members of a
speciﬁc age group, such as adolescents or geriatric age groups.
Studies will be excluded if participants were all in a transient2.
state, such as pregnancy or menopause.
Studies will be excluded if the yoga intervention was modiﬁed3.
to a dance program.
Conference proceedings, editorials, commentaries, and book4.
chapters/book reviews will be excluded.
3.4. Data extraction and management
Two authors will be involved in data extraction and indepen-
dently evaluate the published studies with the selection criteria,
and corresponding authors will be contacted for missing
information in the studies. Data will be extracted on study
design and methods, demographic characteristics of study
participants, as well as details of yoga interventions, control
interventions, and outcome measures PRISMA guidelines will be
used to prepare the data extraction form using MS Excel data
extraction form. This formwill be utilized to standardize the data
collection process.3.5. Selection process
The relevant titles and abstracts will be screened with the
selection criteria and PRISMA guidelines for eligibility by the ﬁrst
author. Potential full-text eligible articles will be downloaded and
reviewed independently by the authors. The corresponding
author will perform a ﬁnal review for the double check to recover
any omitted articles in the analysis. The references of the selected
articles will be imported into EndNote ﬁle to form an initial list of
eligible studies following that duplicates will then be removed. All
the authors will be involved in the selection process, and a ﬁle will
be removed only when there is an agreement that it did not fulﬁll
the eligibility criteria. Any discrepancies associated with selection
of the studies will be resolved by mutual discussions involving the
third reviewer. The entire selection process is illustrated in
Figure 1.
3.6. Data items
The authors will extract 6 categories of data:1. Bibliometric data (1st author, year of publication, country, a
journal of publication, the study period).
Study design (a type of research, details of randomised control2.
trial, randomized cross-over studies and cluster-randomized
trials or quasi-experimental design and the validity of
conﬁrmative diagnosis and method of data collection).
Study participants characteristics (condition, age, gender,3.
race, sample size, and sampling procedures).
Yoga interventions characteristics (yoga type: asana, pra-4.
nayama, meditation, components, frequency, duration).35. Control interventions characteristics (type: usual care or
physical exercise or nontherapeutic intervention, frequency,
duration).
Outcome measures: SBP, DBP; heart rate; respiratory rate;6.
abdominal obesity (waist circumference, waist-hip ratio, index
of central obesity); blood lipid levels (triglycerides, HDL, and
LDL cholesterol); glycemic control (both the intervention and
control group conditions, such as HbA1c, blood pressure, or
fasting blood sugar).
3.7. Study outcomes
3.7.1. Primary outcome. The primary outcome is to measure
the glycemic control (HbA1c, fasting blood glucose [FBG], and
postprandial glucose [PPBG]) in both the intervention and
control group conditions.
3.7.2. Secondary outcomes. The secondary outcomes are to
measure other markers of diabetes management including
triglycerides, HDL, LDL, SBP, DBP, body composition, and
fasting cortisol.3.8. Assessment of risk of bias
Risk of bias of included studies will be assessed using the
Cochrane Risk of Bias Assessment tool that contains several items
under 7 categories such as random sequence generation,
allocation concealment, blinding of participants and investiga-
tors, the blindness of outcome assessments, incomplete outcome
data, selective outcome reporting, and other biases. Based on the
assessment, the studies will be evaluated as low, unclear, or high
bias. The Jadad scale will be used to evaluate the quality of each
trial where three domains in the scale cover Randomization (0–2
points), blinding (0–2 points), and dropouts and withdrawals (0–
1 point). A trial with a score 2 indicates low quality while a
score of ≥3 indicates high quality. Assessment of publication bias
will be performed using funnel plots generated by Comprehensive
Meta-Analysis (CMA) 3.0 software.3.9. Data synthesis
Data will be synthesised into 3 different steps:1. Step 1 will provide a descriptive overview (qualitative data
synthesis or Systematic Review based on selection criteria and
PRISMA guidelines).
Step 2 will provide a quantitative analysis of the characteristics2.
of the selected studies (calculation of pooled estimates and
meta-analysis). Meta-analysis will calculate pooled estimates
of the study ﬁndings on the effectiveness of yoga interventions
on the glycemic status of the prediabetic population.
Step 3 will examine the inﬂuence of study, participant, and3.
outcome characteristics based on the difference in intervention
among the prediabetic population by conducting subgroup
and meta-regression analyses.
3.10. Meta-analysis
Meta-analyses on the effectiveness of yoga interventions on the
glycemic status of the prediabetic population will be performed
using CMA 3.0 for the obtained pooled estimates, standardized
mean difference (SMD) and 95% conﬁdence intervals from the
included studies. Forest plots will be generated to show the
pooled effect size of the study ﬁndings and with random-effects
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Figure 1. Flowchart of systematic review according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Protocols statement.
Ramamoorthi et al. Medicine (2019) 98:3 Medicinemodels of meta-analysis due to between-study heterogeneity
into the model. Heterogeneity will be calculated using Cochrane
Q test and I2 statistic. Q statistics will be estimated for each
outcome and provides a test of the null hypothesis that all
studies in the proposed meta-analysis share a common effect
size. If all studies shared the same effect size, the expected value
of Q would be equal to the degrees of freedom (the number of
studies minus 1). I2 statistics informs what proportion of the
observed variance reﬂects the difference in true effects sizes
rather than sampling error. Z-statistic will be performed to
assess heterogeneity. FBG, PPBG, TC, LDL-c, VLDL-c, HDL-c,
and TG are reported as mg/dL, where studies reported as mmol/
L a numerical conversion to mg/dL will be done. HbA1c is
reported.43.11. Publication bias
Publication bias of the included studieswill be assessed using Egger
bias indicator test, Orwin and Classic fail-safe N test, Begg and
Mazumdar rank collection test, Duval andTweedie trimandﬁll[37]
calculation. An inverted funnel plot will be constructed simulta-
neously alongside the forest plot,with the aid of SMD(SMDvalues
used in themeta-analysis) and the standard error. The symmetrical
funnel plots will indicate low risk, and asymmetrical funnel plots
will indicate a high risk of publication bias.
3.12. Subgroup analyses
Subgroup analyses will be performed according to study,
participant and outcome characteristics and methodologic
[4] International Diabetes Federation. 2017. Available at: https://www.idf.
Ramamoorthi et al. Medicine (2019) 98:3 www.md-journal.comfactors if sufﬁcient studies and retrieved data are identiﬁed and
available. We plan to investigate speciﬁc subgroup analyses
according to differences in intervention and key features of
identiﬁed study participants such as condition, age, gender, race,
sample size, and sampling procedures, follow-up, clinical setting,
of prediabetic participants. Further, speciﬁc subgroup analyses
will be performed based on the outcome measures such as blood
pressure (systolic, diastolic); heart rate; respiratory rate;
abdominal obesity (waist circumference, waist-hip ratio, index
of central obesity); blood lipid levels (triglycerides, HDL, and
LDL cholesterol); glycemic control (both the intervention and
control group conditions, such as HbA1c, blood pressure, or
fasting blood sugar) (if sufﬁcient additional information is
identiﬁed and available). Tables, ﬂowchart, and ﬁgures will be
plotted to depict the results appealingly.4. Meta-regression
Prediabetic participant characteristics such as gender, methods of
data collection, sample size, research quality, and sampling
procedure will be evaluated. A random-effects model will be
selected and assigned to weight for each study by calculating R2
with the quantity of the proposed variance. The heterogeneity of
intervention associations with one or more study variables will be
explained using meta-regression analysis.5. Reporting of this review and its ﬁndings
The ﬁndings will be published as per PRISMA guidelines.[38] A
ﬂowchart will be employed to outline the selection process
(Fig. 1). Text description will be used to review the qualitative
data of the included studies. Outputs of meta-analyses will be
depicted in a forest plot. Publication bias will be represented in
the inverted funnel plot. The search strategy will be provided in
Supplement Table 1 (Supplemental Digital Content, http://links.
lww.com/MD/C749).Author contributions
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